BioCryst Pharmaceuticals, Inc.BCRXNASDAQ
Loading
Price to Sales: Discounted ValuationCompressed
Percentile Rank0
3Y CAGR-38.1%
5Y CAGR-51.5%
Year-over-Year Change
Price-to-sales ratio
3Y CAGR
-38.1%/yr
vs -33.5%/yr prior
5Y CAGR
-51.5%/yr
Recent acceleration
Acceleration
-4.6pp
Decelerating
Percentile
P0
Near historical low
vs 5Y Ago
0x
Contraction
Streak
5 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 1.87 | -45.7% |
| 2024 | 3.45 | -0.7% |
| 2023 | 3.47 | -55.9% |
| 2022 | 7.88 | -50.1% |
| 2021 | 15.78 | -77.4% |
| 2020 | 69.96 | +756.7% |
| 2019 | 8.17 | -79.7% |
| 2018 | 40.32 | +144.9% |
| 2017 | 16.46 | -7.0% |
| 2016 | 17.70 | - |